Badrinath R. Konety
Papers
20
Total Citations
1,444
H-Index
13
About
Badrinath R. Konety is a distinguished urologic oncologist whose research has profoundly shaped the surgical management of bladder cancer, particularly through rigorous comparative evaluation of robotic and open surgical techniques. He is best known as a principal investigator of the landmark RAZOR trial — the Randomized Open versus Robotic Cystectomy study — a phase 3, multicenter, non-inferiority trial that garnered over 760 citations and definitively demonstrated that robot-assisted radical cystectomy achieves comparable oncological outcomes to open surgery. His subsequent three-year follow-up analysis confirmed durable progression-free and overall survival equivalence between approaches, further solidifying these findings. Beyond survival outcomes, Konety has broadened the evidence base by examining perioperative outcomes across international cohorts, health-related quality of life, functional independence recovery, and safety signals from FDA adverse event databases. His systematic reviews and meta-analyses have synthesized global evidence to guide clinical decision-making. With a body of work collectively accumulating over 1,350 citations, Konety's contributions have been instrumental in legitimizing minimally invasive approaches in bladder cancer surgery, directly influencing treatment guidelines and surgical practice worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10